Modulation of the endocannabinoid system reduces inflammatory signalling in canine mammary carcinoma cells
Veterinary Record Open · 2026-06 · 13 (1)
DOI: 10.1002/vro2.70034 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veterinary Record Open, online erschienen am 29.04.2026. Verfasst von Gianluca Antonio Franco und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Science University of Messina Messina Italy. Die Arbeit nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Canine mammary carcinoma (CMC) is characterised by a chronic inflammatory microenvironment resembling human breast cancer; however, the upstream regulatory mechanisms driving this phenotype remain unclear. The endocannabinoid system (ECS) has emerged as a potential modulator of inflammation and tumour biology. This study investigated the role of the ECS in CMC and evaluated the anti‐inflammatory effects of cannabidiol (CBD).
Methods
Primary cell cultures were established from surgically excised CMC tissues, with matched normal mammary epithelium used as controls. Basal mRNA expression of ECS‐related receptors (CB1, CB2, transient receptor potential vanilloid 1 [TRPV1], G‐protein‐coupled receptor 55 [GPR55] and peroxisome proliferator‐activated receptor alpha [PPAR‐α]) and inflammatory mediators (COX‐1, COX‐2, interleukin [IL]‐4, IL‐6, IL‐33, IL‐17A, tumour necrosis factor‐alpha [TNF‐α] and LCN2) was assessed by reverse transcription quantitative polymerase chain reaction. Cytokine secretion (IL‐6, IL‐8, TNF‐α and IL‐17A) was quantified by enzyme‐linked immunosorbent assay. Cell viability assays were performed to determine the 24‐h IC 50 of CBD (32 µM), and sub‐cytotoxic concentrations (3, 10 and 20 µM) were subsequently applied for 24 h.
Results
Canine mammary carcinoma‐derived cells exhibited significant overexpression of ECS receptors (CB1, CB2, TRPV1, GPR55 and PPAR‐α) compared to normal controls. These cells also showed increased secretion of pro‐inflammatory cytokines, including IL‐6, IL‐8, TNF‐α and IL‐17A. Treatment with CBD at 10–20 µM significantly downregulated key inflammatory genes, particularly COX‐2, IL‐6 and TNF‐α, and reduced corresponding cytokine release without compromising cell viability.
Conclusion
The ECS is upregulated in CMC and appears to contribute to the inflammatory tumour microenvironment. Cannabidiol effectively attenuates this inflammatory phenotype at sub‐cytotoxic concentrations, supporting its potential as a therapeutic agent in CMC.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Veterinary Science University of Messina Messina Italy.
- Department of Chemical Biological Pharmaceutical and Environmental Science University of Messina Messina Italy.
- Link University Rome Campus Italy Rome Italy.
ORCID-Profile: Gianluca Antonio Franco, Salvatore Cuzzocrea
Zitieren
APA
Franco, G. A., Marino, Y., Rifici, C., Fusco, R., di Paola, D., Cuzzocrea, S., Catone, G., Vullo, C., & Gugliandolo, E. (2026). Modulation of the endocannabinoid system reduces inflammatory signalling in canine mammary carcinoma cells. Veterinary Record Open, 13(1). https://doi.org/10.1002/vro2.70034
Vancouver
Franco GA, Marino Y, Rifici C, Fusco R, di Paola D, Cuzzocrea S, et al. Modulation of the endocannabinoid system reduces inflammatory signalling in canine mammary carcinoma cells. Veterinary Record Open. 2026;13(1). doi:10.1002/vro2.70034
BibTeX
@article{Franco2026,
author = {Franco, Gianluca Antonio and Marino, Ylenia and Rifici, Claudia and Fusco, Roberta and di Paola, Davide and Cuzzocrea, Salvatore and Catone, Giuseppe and Vullo, Cecilia and Gugliandolo, Enrico},
title = {Modulation of the endocannabinoid system reduces inflammatory signalling in canine mammary carcinoma cells},
journal = {Veterinary Record Open},
year = {2026},
volume = {13},
number = {1},
doi = {10.1002/vro2.70034}
}
EUVIMED